Safety and Efficacy Study of Novel Gene Therapy AGX-08 for Geographic Atrophy

Summary

This is AGX-08's safety, tolerability, and efficacy in Geographic Atrophy first-in-human study. This trial is meant to evaluate the safety and efficacy of AGX-08 in Geographic Atrophy patients. Unilateral intravitreal injections (IVT) will be given into the subject's Study Eye.

Timeline

Start

2026-07-01

Primary completion

2028-12-30

Completion

2029-12-30

Drugs

Indications